Polymyalgia Rheumatica After COVID-19 Vaccination: Data from the EudraVigilance Database

Cláudia Pinto Oliveira; Sofia Ferreira Azevedo; Carolina Vilafanha; Ana Rita Prata; Anabela Barcelos

doi:10.20344/amp.20952

Polymyalgia Rheumatica After COVID-19 Vaccination: Data from the EudraVigilance Database

Authors

Cláudia Pinto Oliveira Rheumatology Department. Centro Hospitalar do Baixo Vouga. Aveiro; Centro Académico Clínico Egas Moniz Health Alliance. Universidade de Aveiro. Aveiro. https://orcid.org/0000-0002-6824-3688
Sofia Ferreira Azevedo Rheumatology Department. Centro Hospitalar do Baixo Vouga. Aveiro; Centro Académico Clínico Egas Moniz Health Alliance. Universidade de Aveiro. Aveiro. https://orcid.org/0000-0002-1786-7925
Carolina Vilafanha Rheumatology Department. Centro Hospitalar do Baixo Vouga. Aveiro; Centro Académico Clínico Egas Moniz Health Alliance. Universidade de Aveiro. Aveiro. https://orcid.org/0000-0001-6779-101X
Ana Rita Prata Rheumatology Department. Centro Hospitalar do Baixo Vouga. Aveiro; Centro Académico Clínico Egas Moniz Health Alliance. Universidade de Aveiro. Aveiro. https://orcid.org/0000-0002-9432-2216
Anabela Barcelos Rheumatology Department. Centro Hospitalar do Baixo Vouga. Aveiro; Centro Académico Clínico Egas Moniz Health Alliance. Universidade de Aveiro. Aveiro. https://orcid.org/0000-0002-4116-8964

DOI:

https://doi.org/10.20344/amp.20952

Keywords:

Adverse Drug Reaction Reporting Systems, COVID-19 Vaccines, Drug Monitoring, Pharmacovigilance, Polymyalgia Rheumatica

Abstract

N/a.

Downloads

Download data is not yet available.

References

Falsetti P, Conticini E, Acciai C, Baldi C, Bardelli M, Gentileschi S, et al. Polymyalgia rheumatica following infective triggers or vaccinations: a different subset of disease? Reumatologia. 2020;58:76-80. DOI: https://doi.org/10.5114/reum.2020.95360

Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165:386-401. DOI: https://doi.org/10.1111/imm.13443

Ottaviani S, Juge PA, Forien M, Ebstein E, Palazzo E, Dieudé P. Polymyalgia rheumatica following COVID-19 vaccination: a case-series of ten patients. Joint Bone Spine. 2022;89:105334. DOI: https://doi.org/10.1016/j.jbspin.2021.105334

Downloads

Published

2024-04-12

How to Cite

Pinto Oliveira C, Ferreira Azevedo S, Vilafanha C, Prata AR, Barcelos A. Polymyalgia Rheumatica After COVID-19 Vaccination: Data from the EudraVigilance Database. Acta Med Port [Internet]. 2024 Apr. 12 [cited 2024 Nov. 21];37(5):396-7. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/20952

Download Citation

Issue

Vol. 37 No. 5 (2024): May

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.